Currently in its third year of funding, The University of Iowa/ Mayo Clinic Lymphoma Specialized Program (UI/MC SPORE) is one of two Lymphoma Specialized Programs supported by the National Cancer Institute. This translational, multidisciplinary, inter-institutional grant also includes career development and developmental research programs. UI/MC SPORE draws on the complementary strengths of Iowa’s Holden Comprehensive Cancer Center and Mayo Clinic Comprehensive Cancer Center. Both Centers have extensive experience in lymphoma research, from basic investigation through innovative clinical trials. The collaboration of two comprehensive cancer centers permits extensive translational lymphoma research that would not be possible at each center alone. The overall theme of the UI/MC SPORE is that understanding the anti-tumor activity of anti-lymphoma monoclonal antibody ( moAb) therapy enhances our ability to treat lymphoma. Cores within the grant include Biostatistics, Biospecimens, Immunology, Clinical Trials and Administration. All units within the SPORE draw on the resources of both institutions to expedite the translation of discoveries into new and better approaches to prevention and treatment. SPORE investigators have expertise in a broad range of fields including genetics, signaling, cellular immunology, antibody-based therapy, clinical immunotherapy, clinical trial design, tumor imaging, biostatistics and epidemiology. The UI/MC SPORE holds a monthly videoconference where research findings are presented and discussed by both trainees and faculty.

• Lymphoma Research and Training Program Mentors